🏛️ Verified NIH Record • Updated 2024-09-16
Risk Factors for Falls and Neurocognitive Disorders CLSA (NCT03628768)
Risk Factors for Falls and Neurocognitive Disorders in the Older Canadian Population: A Population-based Cross-sectional Study
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Jewish General Hospital
🩺 Plain-English Summary (8th-Grade Level)
The study evaluates the association between the neurocognitive decline and falls.
Who can join: Review the eligibility criteria below.
Location: Jewish General Hospital — Montreal, Quebec
Age range: 65 Years
🧪 Interventions in This Study
- Data collection (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Jewish General Hospital — Montreal, Quebec
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Neurocognitive Disorders
- CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes — Calgary, Alberta
- Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic — Miami, Florida
- Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study — Portland, Oregon
Explore by condition: All Neurocognitive Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.